Inhalation Anesthesia Market Research Report - Global Forecast till 2025

Global Inhalation Anesthesia Market Research Report: Information by Product (Sevoflurane, Isoflurane, Desflurane), Application (Induction, Maintenance) and Region - Global Forecast till 2025

ID: MRFR/HC/6587-HCR | February 2021 | Region: Global | 90 pages

Market Scenario


The global inhalation anesthesia market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 1.12 billion in 2018 and is projected to register a CAGR of 3.8% over the forecast period.


Inhalational anesthetics are used for the induction and maintenance of general anesthesia as well as sedation. They are usually preferred for maintenance because they allow more precise control of the anesthetic state and do so at low cost.


The increasing geriatric population is one of the key factors driving the inhalation anesthesia market as they are highly prone to degenerative diseases and chronic illnesses, which eventually leads to a rise in surgeries and therapeutics. According to WHO, it is estimated that the world’s population aged 60 years and older are likely to double from 12% to 22% by 2050.


Various other factors such as the rise in surgical procedures, rising prevalence of cardiovascular and respiratory system-related diseases along with technological advancements, and a rise in regulatory approvals drive the growth of the market.


However, the increasing concern about greenhouse gas emissions will hamper market growth over the forecast period.


Segmentation


The global inhalation anesthesia market is segmented based on product, application, and region.


The global market for inhalation anesthesia, by product, is segmented into sevoflurane, isoflurane, and desflurane.


Based on application, the market is segmented into induction and maintenance.


In the current scope of the study, the segments mentioned above are covered into the four global regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East and African region.


The inhalation anesthesia market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European inhalation anesthesia market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The inhalation anesthesia market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The inhalation anesthesia market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key Players



  • Baxter International Inc.

  • Halocarbon Products Corporation

  • Hikima Pharmaceuticals plc.

  • Lunan Pharmaceutical Group Co. Ltd

  • Piramal Enterprises Limited

  • Jiangsu Hengrui Medicine Co. Ltd

  • Fresenius Kabi AG

  • AbbVie Inc.


Regional Market Summary


Global Inhalation Anesthesia Market Share (%), by Region, 2018
 Inhalation Anesthesia Market


Sources: MRFR Analysis


The Americas dominated the global market for inhalation anesthesia owing to the rising geriatric population within the region. As per the data suggested by the United Census Bureau, by 2060, the US is projected to grow by 79 million people, from about 326 million today to 404 million. The population is projected to cross the 400-million threshold in 2058. Additionally, according to the WHO, in the US, more than 20% of the total population is likely to be aged 65 years or over by 2030. Moreover, rising cases of surgical procedures along with the participation of market players are also strongly impacting the growth of the Americas inhalation anesthesia market. For instance, according to the American Society for Aesthetic Plastic Surgery, around 1, 542, 67 surgical cosmetic procedures were conducted in 2017. Similarly, according to the Center for Diseases Control and Prevention, approximately 46.5 million surgical procedures are performed every year in the US.


 In 2018, it was estimated that Europe stood second in the global inhalation anesthesia market. Technological advancements, along with the availability of funding opportunities in research and innovation, will support market growth.


Asia-Pacific (APAC) is expected to represent the phenomenal market growth throughout the forecast period due to rising prevalence of chronic conditions, growing awareness about medications, and increasing healthcare expenditure. During 2016-2017, Australia spent nearly USD181 billion on health, which is more than USD 7,400 per person and 10% of overall economic activity.


On the other hand, the Middle East and Africa held the least share in the global inhalation anesthesia market due to the low economic development, especially within the African region.


Market Segmentation


Global Inhalation Anesthesia Market, by Product



  • Sevoflurane

  • Isoflurane

  • Desflurane


Global Inhalation Anesthesia Market, by Application



  • Induction

  • Maintenance


Intended Audience



  • Medical devices companies

  • Government and private laboratories

  • Research and development (R&D) companies

  • Research laboratories

  • Market research and consulting service providers



Frequently Asked Questions (FAQ) :


The inhalation anesthesia market in 2018 was USD 1.12 billion.

The inhalation anesthesia market would grow with a CAGR of 3.8% CAGR during the forecast period of 2019 to 2024.

The concern regarding increasing greenhouse gas emissions can deter the inhalation anesthesia market growth rate.

The US will lead the American inhalation anesthesia market.

The Asia Pacific inhalation anesthesia market would be the fastest-growing region.

Table of Contents
Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Macroeconomic Indicators

4.5 Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Opportunities

5.4 Pricing Analysis

Chapter 6. Global Inhalation Anesthesia Market, by Product

6.1 Introduction

6.2 Sevoflurane

Market Estimates & Forecast, by Region, 2019–2024

Market Estimates & Forecast, by Country, 2019–2024

6.3 Isoflurane

Market Estimates & Forecast, by Region, 2019–2024

Market Estimates & Forecast, by Country, 2019–2024

6.3 Desflurane

Market Estimates & Forecast, by Region, 2019–2024

Market Estimates & Forecast, by Country, 2019–2024
Chapter 7. Global Inhalation Anesthesia Market, by Application

7.1 Introduction

7.2 Induction

Market Estimates & Forecast, by Region, 2019–2024

Market Estimates & Forecast, by Country, 2019–2024

7.3 Maintenance

Market Estimates & Forecast, by Region, 2019–2024

Market Estimates & Forecast, by Country, 2019–2024

Chapter 8. Global Inhalation Anesthesia Market, by Region

8.1 Introduction

8.2 Americas

8.2.1 North America

8.2.1.1 US

8.2.1.2 Canada

8.2.2 South America

8.3 Europe

8.3.1 Western Europe

8.3.1.1 Germany

8.3.1.2 France

8.3.1.3 Italy

8.3.1.4 Spain

8.3.1.5 UK

8.3.1.6 Rest of Western Europe

8.3.2 Eastern Europe

8.4 Asia-Pacific

8.4.1 Japan

8.4.2 China

8.4.3 India

8.4.4 Australia

8.4.5 South Korea

8.4.6 Rest of Asia-Pacific

8.5 Middle East & Africa

8.5.1 Middle East

8.5.2 Africa

Chapter 9. Company Landscape

9.1 Introduction

9.2 Market Share Analysis

9.3 Key Development & Strategies

Chapter 10. Company Profiles

10.1 Halocarbon Products Corporation

10.1.1 Company Overview

10.1.2 Product Overview

10.1.3 Financials Overview

10.1.4 Key Developments

10.1.5 SWOT Analysis

10.2 Baxter

10.2.1 Company Overview

10.2.2 Product Overview

10.2.3 Financial Overview

10.2.4 Key Developments

10.2.5 SWOT Analysis

10.3 Hikima Pharmaceuticals plc.

10.3.1 Company Overview

10.3.2 Product Overview

10.3.3 Financial Overview

10.3.4 Key Development

10.3.5 SWOT Analysis

10.4 Lunan Pharmaceutical Group Co. Ltd

10.4.1 Company Overview

10.4.2 Product Overview

10.4.3 Financial Overview

10.4.4 Key Development

10.4.5 SWOT Analysis

10.5 Piramal Enterprises Limited

10.5.1 Company Overview

10.5.2 Product Overview

10.5.3 Financial overview

10.5.4 Key Developments

10.5.5 SWOT Analysis

10.6 Jiangsu Hengrui Medicine Co. Ltd

10.6.1 Company Overview

10.6.2 Product Overview

10.6.3 Financial Overview

10.6.4 Key Developments

10.6.5 SWOT Analysis

10.7 Fresenius Kabi AG

10.7.1 Overview

10.7.2 Product Overview

10.7.3 Financials

10.7.4 Key Developments

10.7.5 SWOT Analysis

10.8 AbbVie Inc.

10.8.1 Overview

10.8.2 Product Overview

10.8.3 Financials

10.8.4 Key Developments

10.8.5 SWOT Analysis

10.9 Other

Chapter 11 MRFR Conclusion

11.1 Key Findings

11.1.1 From CEO’s Viewpoint

11.1.2 Unmet Needs of the Market

11.2 Key Companies to Watch

11.3 Predictions for the global inhalation anesthesia market

Chapter 12 Appendix

LIST OF TABLES

Table 1 Inhalation Anesthesia Market Synopsis, 2019–2024

Table 2 Inhalation Anesthesia Market Estimates and Forecast, 2019–2024 (USD Million)

Table 3 Global Inhalation Anesthesia Market, by Region, 2019–2024 (USD Million)

Table 4 Global Inhalation Anesthesia Market, by Product, 2019–2024 (USD Million)

Table 6 Global Inhalation Anesthesia Market, Application, 2019–2024 (USD Million)

Table 7 North America: Inhalation Anesthesia Market, by Product, 2019–2024 (USD Million)

Table 9 North America: Inhalation Anesthesia Market, Application, 2019–2024 (USD Million)

Table 10 US: Inhalation Anesthesia Market, by Product, 2019–2024 (USD Million)

Table 12 US: Inhalation Anesthesia Market, Application, 2019–2024 (USD Million)

Table 13 Canada: Inhalation Anesthesia Market, by Product, 2019–2024 (USD Million)

Table 15 Canada: Inhalation Anesthesia Market, Application, 2019–2024 (USD Million)

Table 16 South America: Inhalation Anesthesia Market, by Product, 2019–2024 (USD Million)

Table 18 South America: Inhalation Anesthesia Market, Application, 2019–2024 (USD Million)

Table 19 Europe: Inhalation Anesthesia Market, by Product, 2019–2024 (USD Million)

Table 21 Europe: Inhalation Anesthesia Market, Application, 2019–2024 (USD Million)

Table 22 Western Europe: Inhalation Anesthesia Market, by Product, 2019–2024 (USD Million)

Table 24 Western Europe: Inhalation Anesthesia Market, by Application, 2019–2024(USD Million)

Table 25 Eastern Europe: Inhalation Anesthesia Market, by Product, 2019–2024 (USD Million)

Table 27 Eastern Europe: Inhalation Anesthesia Market, Application, 2019–2024(USD Million)

Table 28 Asia-Pacific: Inhalation Anesthesia Market, by Product, 2019–2024 (USD Million)

Table 30 Asia-Pacific: Inhalation Anesthesia Market, Application, 2019–2024 (USD Million)

Table 31 Middle East & Africa: Inhalation Anesthesia Market, by Product, 2019–2024 (USD Million)

Table 33 Middle East & Africa: Inhalation Anesthesia Market, Application, 2019–2024(USD Million)
LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Inhalation Anesthesia Market

Figure 3 Market Dynamics for Global Inhalation Anesthesia Market

Figure 4 Inhalation Anesthesia Market Share, by Product, 2018

Figure 6 Inhalation Anesthesia Market Share, Application, 2018

Figure 7 Inhalation Anesthesia Market Share, by Region, 2018

Figure 8 North America: Inhalation Anesthesia Market Share, by Country, 2018

Figure 9 Europe: Inhalation Anesthesia Market Share, by Country, 2018

Figure 10 Asia-Pacific: Inhalation Anesthesia Market Share, by Country, 2018

Figure 11 Middle East & Africa: Inhalation Anesthesia Market Share, by Region, 2018

Figure 12 Inhalation Anesthesia Market: Company Share Analysis, 2018 (%)

Figure 13 Halocarbon Products Corporation: Key Financials

Figure 14 Halocarbon Products Corporation: Segmental Revenue

Figure 15 Halocarbon Products Corporation: Geographical Revenue

Figure 16 Baxter: Key Financials

Figure 17 Baxter: Segmental Revenue

Figure 18 Baxter: Geographical Revenue

Figure 19 Hikima Pharmaceuticals plc.: Key Financials

Figure 20 Hikima Pharmaceuticals plc.: Segmental Revenue

Figure 21 Hikima Pharmaceuticals plc.: Geographical Revenue

Figure 22 Piramal Enterprises Limited.: Key Financials

Figure 23 Piramal Enterprises Limited: Segmental Revenue

Figure 24 Piramal Enterprises Limited: Geographical Revenue



This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.